The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom. immunotherapy - enhanced uptake of new immuno-moieties by immune cells that can then mount an immune attack against cancer cells. chemotherapy - improved and targeted delivery of existing chemotherapeutic agents to tumor sites, as well as ii. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months Midasolve platform is a innovative nanosaccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors Midacore platform is a edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale ie i. The chart is searching for a support level which was established last week between.
MTP STOCK PRICE CODE
It is focused on the research and development of medicines for rare cancers, via both in house programmes as well as partnered programmes. MTP has reached another all time low and is currently printing a double bullish divergence on the weekly chart. Midatech Pharma Plc Ord 0.1P is listed on the London Stock Exchange, trading with ticker code MTPH. Midatech Pharma Plc is a drug delivery technology company.
0 kommentar(er)
